Loading clinical trials...
Loading clinical trials...
A Double-blind, Randomized, Multi-center Phase III Clinical Trial to Evaluate the Safety and Efficacy of CJ-30060 Compared With Amlodipine/Valsartan Combination Therapy and Valsartan/Rosuvastatin Combination Therapy in Hypertensive Patients With Hyperlipidemia
Conditions
Interventions
Amlodipine 10 mg + Valsartan 160 mg + Rosuvastatin 20 mg
Amlodipine 10 mg + Valsartan 160 mg
+1 more
Start Date
October 14, 2016
Primary Completion Date
September 4, 2017
Completion Date
September 4, 2017
Last Updated
May 30, 2018
Lead Sponsor
HK inno.N Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions